Madrigal Pharmaceuticals Inc

NASDAQ:MDGL  
437.85
+0.68 (+0.16%)
7:58:32 PM EDT: $443.00 +5.15 (+1.18%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)9.77B
Current PEN/A
Forward PE N/A
2yr Forward PE 103.02
See more stats
Estimates Current Quarter
Revenue$243.95 Million
Adjusted EPS-$1.95
See more estimates
10-Day MA$412.39
50-Day MA$335.23
200-Day MA$319.86
See more pivots

Madrigal Pharmaceuticals Inc Stock, NASDAQ:MDGL

200 Barr Harbor Drive, Suite 200, West Conshohocken, Pennsylvania 19428
United States of America
Phone: +1.267.824.2827
Number of Employees: 528

Description

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on March 2000 and is headquartered in West Conshohocken, PA.